Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy [NA]

View source ↗

Summary

A University of Texas at Austin study investigates CO2 reactivity as a biomarker for non-response to exposure-based therapy across multiple anxiety disorders an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas at Austin | Conditions: Obsessive-Compulsive Disorder, Post Traumatic Stress Disorder | NA | Status: RECRUITING